Propranolol, din a wɔde nim no wɔ dwa so ne Inderal. Ɛyɛ aduro bi a ɛka beta blocker nnuro abusuakuo no ho.[1] Wɔde sa mogyaborosoɔ, akoma a ɛbɔ paripari, thyrotoxicosis, capillary hemangiomas ne ade[1][2][3] Aduro no boa sɔ tipaeɛ a wɔfrɛ no migraine headaches nso ano. Ɛsɔ akoma yadeɛ ahodoɔ bi nso ano.[1] Yɛde fa yɛn anom na ɛkɔ yɛn nipadua mu.[1].[1][1][4]

Baabi a Menyaa Mmoa Firiiɛ

sesa
  1. 1.0 1.1 1.2 1.3 1.4 1.5 "Propranolol hydrochloride". Monograph. The American Society of Health-System Pharmacists. Archived from the original on 1 January 2015. Retrieved 1 January 2015.
  2. Davidson JR (2006). "Pharmacotherapy of social anxiety disorder: what does the evidence tell us?". The Journal of Clinical Psychiatry. 67 (Suppl 12): 20–26. doi:10.1016/j.genhosppsych.2005.07.002. PMID 17092192.
  3. Chinnadurai S, Fonnesbeck C, Snyder KM, Sathe NA, Morad A, Likis FE, McPheeters ML (February 2016). "Pharmacologic Interventions for Infantile Hemangioma: A Meta-analysis" (PDF). Pediatrics. 137 (2): e20153896. doi:10.1542/peds.2015-3896. PMID 26772662. S2CID 30459652.
  4. Bryson PD (1997). Comprehensive review in toxicology for emergency clinicians (3 ed.). Washington, DC: Taylor & Francis. p. 167. ISBN 9781560326120. Archived from the original on 24 March 2017.